new_0222_0333|CRBU|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0333|CRBU|1|Caribou Biosciences Inc Total Current Assets (Quarterly) (USD)|Caribou Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Caribou Biosciences Inc Inventories (Quarterly) (USD)|Caribou Biosciences Inc Net PP&E (Quarterly) (USD)|Caribou Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Caribou Biosciences Inc Total Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Deposits (Quarterly) (USD)|Caribou Biosciences Inc Book Value (Quarterly) (USD)|Caribou Biosciences Inc Retained Earnings (Quarterly) (USD)|Caribou Biosciences Inc Treasury Stock (Quarterly) (USD)|Caribou Biosciences Inc EV to Revenues|Caribou Biosciences Inc EV to Earnings|Caribou Biosciences Inc EV to Free Cash Flow|Caribou Biosciences Inc EV to Assets (Quarterly)|Caribou Biosciences Inc PS Ratio|Caribou Biosciences Inc PE Ratio|Caribou Biosciences Inc Price to Book Value|Caribou Biosciences Inc PEG Ratio|Caribou Biosciences Inc Debt to Equity Ratio|Caribou Biosciences Inc Dividend Yield|Caribou Biosciences Inc Shareholder Yield (TTM)|Caribou Biosciences Inc Percent of Shares Outstanding Short|Caribou Biosciences Inc Total Receivables (Quarterly) (USD)|Caribou Biosciences Inc Total Payables (Quarterly) (USD)|Caribou Biosciences Inc Total Capital Stock (Quarterly) (USD)|Caribou Biosciences Inc Return on Invested Capital|Caribou Biosciences Inc Quality Ratio Score|Caribou Biosciences Inc Momentum Score|Caribou Biosciences Inc Beta (1Y)|Caribou Biosciences Inc Sustainable Growth Rate (TTM)|Caribou Biosciences Inc Institutional Investor Ownership Percentage|Caribou Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Caribou Biosciences Inc Total Employees (Annual)|Caribou Biosciences Inc EPS Diluted (Quarterly) (USD)|Caribou Biosciences Inc SG&A Expense (Quarterly) (USD)|Caribou Biosciences Inc Shares Outstanding|Caribou Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Caribou Biosciences Inc Ordinary Shares Number (Quarterly)|Caribou Biosciences Inc Payout Ratio|Caribou Biosciences Inc Quick Ratio (Quarterly)|Caribou Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Caribou Biosciences Inc Stock Buybacks (Quarterly) (USD)|Caribou Biosciences Inc Effective Tax Rate (TTM)|Caribou Biosciences Inc Return on Equity|Caribou Biosciences Inc Net Income (TTM) (USD)|Caribou Biosciences Inc Revenue (TTM) (USD)|Caribou Biosciences Inc Dividend Per Share (Quarterly) (USD)|Caribou Biosciences Inc Revenue (Quarterly) (USD)|Caribou Biosciences Inc Gross Profit (Quarterly) (USD)|Caribou Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Caribou Biosciences Inc Net Income (Quarterly) (USD)|Caribou Biosciences Inc Net Interest Income (Quarterly) (USD)|Caribou Biosciences Inc Price (USD)|Caribou Biosciences Inc Total Return Price (USD)|Caribou Biosciences Inc Enterprise Value (USD)|Caribou Biosciences Inc 30-Day Average Daily Volume|Caribou Biosciences Inc 1 Year Price Returns (Daily)|Caribou Biosciences Inc Short Interest|Caribou Biosciences Inc PE Ratio (Forward)|Caribou Biosciences Inc PE Ratio (Forward 1y)|Caribou Biosciences Inc PS Ratio (Forward)|Caribou Biosciences Inc PS Ratio (Forward 1y)|Caribou Biosciences Inc Quarterly EPS Estimates (USD)|Caribou Biosciences Inc Quarterly Revenue Estimates (USD)|Caribou Biosciences Inc Quarterly EPS Surprise|Caribou Biosciences Inc Quarterly Revenue Surprise|Caribou Biosciences Inc Quarterly Actual EPS (USD)|Caribou Biosciences Inc Quarterly Actual Revenue (USD)|Caribou Biosciences Inc Revenue Estimates for Current Fiscal Year (USD)|Caribou Biosciences Inc Revenue Estimates for Next Fiscal Year (USD)|Caribou Biosciences Inc Price Target (USD)|Caribou Biosciences Inc Consensus Recommendation|Caribou Biosciences Inc Price Target Num Estimates|Caribou Biosciences Inc EPS Estimates for Current Fiscal Year (USD)|Caribou Biosciences Inc EPS Estimates for Next Fiscal Year (USD)|Caribou Biosciences Inc Research and Development Expense (Quarterly) (USD)|Caribou Biosciences Inc Reconciled Depreciation (Quarterly) (USD)|Caribou Biosciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Caribou Biosciences Inc Land and Improvements (Quarterly) (USD)|Caribou Biosciences Inc Buildings and Improvements (Quarterly) (USD)|Caribou Biosciences Inc Other Properties (Quarterly) (USD)|Caribou Biosciences Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0333|CRBU|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0333|CRBU|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0333|CRBU|5|91|91||91||91|91|91||91|91||1.43835616438||1.43835616438||1.43835616438||1.4387755102||91|1.43835616438||15.4166666667|91|91|91|92|||||30.6666666667|91.3333333333||91.3333333333|91.3333333333|15.5714285714||91|91|91|91.3333333333|91.25|91||91|91||91.3333333333||91.3333333333|91.3333333333|91.3333333333|1.43835616438|1.43835616438|1.43835616438|1.44444444444||15.4166666667|||1.44117647059|1.44117647059|92|92|92|92|92|92|20.1111111111|30.1666666667|18.4|16.7272727273|18.4|45.25|36.2|91.3333333333|91.3333333333|91.3333333333|||91|91||
new_0222_0333|CRBU|6|3|3||3||3|3|3||3|3||146||146||146||98||3|146||12|3|3|3|1|||||6|6||6|6|7||3|3|3|6|4|3||3|3||6||6|6|6|146|146|146|117||12|||34|34|2|2|1|1|1|1|9|6|10|11|10|4|5|6|6|6|||3|3||
new_0222_0333|CRBU|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0333|CRBU|202003||||||||||||||||||||||||||||||||||27.6574||-0.3543|3.489||||||-0.3307|||||||1.701||-11.002|-9.8|0.139||||||||||||||||||||||||8.641|0.226|0.003||||||
new_0222_0333|CRBU|202006||||||||||||||||||||||||||||||||||27.6574||-0.0677|3.153||||||-0.0677|||||||8.478||-1.922|-1.872|0.006||||||||||||||||||||||||7.58|0.228|0.005||||||
new_0222_0333|CRBU|202009||||||||||||||||||||||||||||||||||27.6574||-0.2868|3.247||||||-0.2868|||||||1.198||-8.146|-7.933|-0.002||||||||||||||||||||||||6.18|0.226|0.006||||||
new_0222_0333|CRBU|202012|24.306|15.953||3.502||18.16|12.389|5.771||-23.437|-30.871||||||||||0.0882||||5.16|2.606|41.324|||||||27.6574||-0.5316|4.173|||54.7092||1.7042|-0.5316||5.035||-34.308|12.361||0.984||-15.057|-14.703|0.073||||||||||||||||||||||||12.024|0.22|0.006|||5.038|0.38||
new_0222_0333|CRBU|202103|155.925|145.924||3.38||53.504|22.21|31.294||-35.689|-44.03||||||||||0.0138||||5.825|3.122|150.151|||||||27.6574||-0.48|4.596|||54.7092||6.8325|-0.48||1.6116||-37.667|12.246||1.586||-13.159|-13.159|-0.001||||||||||||||||||||||||10.165|0.221|0.005|||5.135|0.38||
new_0222_0333|CRBU|202106|142.967|129.524||4.408||55.938|26.007|29.931||-47.691|-58.341||179.1219||-66.8552||106.3329|||||||0.7569|8.407|4.034|150.151|-63.1681|||||17.0766|54.7092|76|-0.2616|5.113|56.7092||54.7092||5.3036|-0.2905||1.1189||-50.106|5.244||1.476||-14.311|-14.311|0.044|16.2|16.2|939.315|||429224|||||0.4728|30|-427.6296|-95.08|-1.549|1.476|27.5|8.3333|29.6667|1.6667|3|-0.83|-1.5159|12.327|0.23|0.002|||5.949|0.391|27.2|
new_0222_0333|CRBU|202109|449.047|435.31||4.477||57.559|26.158|31.401||404.401|-79.315||124.3174|-15.7949|-44.843|2.1591|115.9684||3.5428||||-22.4065|2.753|7.785|3.482|0.006|-39.3215||||-84.8796|65.9808|45.8896||-0.46|6.76|60.0213||60.0213||16.9392|-0.4076|-321.02|0.5575|-84.8796|-63.147|8.023||3.977||-20.974|-20.974|0.022|23.87|23.87|997.3984|863955.4667||1652365|||||-0.24|3|-68.75|32.5667|-0.405|3.977|11.531|12.5|30.6667|1.6667|3|-1.54|-1.47|15.833|0.26||||6.245|0.401|22.11|18.59
new_0222_0333|CRBU|202112|||||||||||||58.9541||-21.2656||73.3123||2.246|||||4.3884|||||||||66.9579||||||||||||||||||||||15.09|15.09|472.9888|415289.8||2641461|||66.7867|49.7698|-0.34|4.8242|||||11.4372|16.9068|29.1667|1.1667|6|-1.765|-1.95||||||||10.73|10